NEW YORK, Sept. 9 (UPI) — A patient who underwent the world’s first whole-eye and partial-face transplant has healed astonishingly well more than a year after the 21-hour surgery, a … Click to Continue » View original article Contributor:
Urban wet markets are fertile grounds for viral transmission, experts say. Outbreaks of bird flu have already occurred. View original article Contributor: Apoorva Mandavilli and Juan Arredondo
Losing weight can help a person with obesity — especially those with diabetes — fend off serious infections, new data shows. It’s an important finding, since “up to one in … Click to Continue » View original article Contributor:
In exercise bike tests, twentysomethings who’d been vaping for at least two years had much lower exercise capacity than those who didn’t, and the losses were equal to those of … Click to Continue » View original article Contributor:
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study … Click to Continue » View original article Contributor:
A sheriff fought to give prisoners addicted to opioids a shot that suppresses cravings for a month. Upon release, they were more likely to continue treatment. View original article Contributor: Jan Hoffman
Priya, an engineer in California, was on a deadline. Under pressure, she emailed a younger friend working on the same project to ask for some data that the project needed to get done on time. She and the woman weren’t super close, but Priya considered her colleague an ally and a buddy—previously they had “trauma-bonded,” … Read more
When I left my father’s condo for the airport on a sunny March day in 2018, I did not once think that he might kill himself. Yes, his depression had returned, dense and unsteadying. But he had just come home from a week of voluntary inpatient care at the psychiatric hospital. He had a psychiatrist, … Read more
The weight-loss drugs that have become so popular in recent years actually began as diabetes medications, and a new study shows that they continue to provide strong protection against that chronic disease. Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss—announced recently that in its longest study … Read more
Anxiety and Complementary Health Approaches National Institutes of Health (NIH) (.gov) >View original article Contributor: